Evidence map›Paper›PMID 31421373›Full record

ArticleThe Journal of surgical research2020

Enhanced Mitochondrial DNA Repair Resuscitates Transplantable Lungs Donated After Circulatory Death.

Yong B Tan, Viktor M Pastukh, Olena M Gorodnya, Madhuri S Mulekar, Jon D Simmons, Tiago N Machuca, Thomas M Beaver, Glenn L Wilson, Mark N Gillespie

Open access · greenAbstract read
In one paragraph

Article in The Journal of surgical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. PFKFB3 Inhibits Fructose Metabolism in Pulmonary Microvascular Endothelial Cells.American journal of respiratory cell and molecular biology · 2023
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yong B TanDepartment of Surgery, College of Medicine, University of South Alabama, Mobile, Alabama.
Viktor M PastukhDepartment of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama.
Olena M GorodnyaDepartment of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama.
Madhuri S MulekarDepartment of Mathematics and Statistics, College of Medicine, University of South Alabama, Mobile, Alabama.
Jon D SimmonsDepartment of Surgery, College of Medicine, University of South Alabama, Mobile, Alabama; Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama.
Tiago N MachucaDepartment of Surgery, College of Medicine, University of Florida, Gainesville, Florida.
Thomas M BeaverDepartment of Surgery, College of Medicine, University of Florida, Gainesville, Florida.
Glenn L WilsonExscien Corporation, Mobile, Alabama.
Mark N GillespieDepartment of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama. Electronic address: mgillesp@southalabama.edu.
University of South Alabama · USUniversity of Florida · USExscien (United States) · US

Funding

DNA LESIONS AND GENE EXPRESSION IN HYPOXIC LUNG DISEASER01HL058234 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI GILLESPIE, MARK N · 1998 to 2018
$5.2M
MtDNA repair: An isolated pharmacologic target in acute lung injuryR01HL113614 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI GILLESPIE, MARK N · 2012 to 2021
$3.5M
Mitochondrial DNA repair agents for acute lung injuryR44HL114225 · NHLBI · EXSCIEN CORPORATION · PI GILLESPIE, MARK N, WILSON, GLENN · 2015 to 2017
$3.2M
mtDNA DAMPS: a pharmacologic target in multi-organ system failureK08GM109113 · NIGMS · UNIVERSITY OF SOUTH ALABAMA · PI SIMMONS, JON DAVID · 2016 to 2019
$756k
Mitochondrial DNA repair agents for acute lung injuryR41HL114225 · NHLBI · EXSCIEN CORPORATION · PI GILLESPIE, MARK N · 2012 to 2012
$155k
NHLBI NIH HHS R01 HL058234NHLBI NIH HHS R01 HL113614NHLBI NIH HHS R41 HL114225NHLBI NIH HHS R44 HL114225NIGMS NIH HHS K08 GM109113
6 · The paper itself

Abstract

backgroundTransplantation of lungs procured after donation after circulatory death (DCD) is challenging because postmortem metabolic degradation may engender susceptibility to ischemia-reperfusion (IR) injury. Because oxidative mitochondrial DNA (mtDNA) damage has been linked to endothelial barrier disruption in other models of IR injury, here we used a fusion protein construct targeting the DNA repair 8-oxoguanine DNA glycosylase-1 (OGG1) to mitochondria (mtOGG1) to determine if enhanced repair of mtDNA damage attenuates endothelial barrier dysfunction after IR injury in a rat model of lung procurement after DCD. MATERIALS AND

methodsLungs excised from donor rats 1 h after cardiac death were cold stored for 2 h after which they were perfused ex vivo in the absence and presence of mt-OGG1 or an inactive mt-OGG1 mutant. Lung endothelial barrier function and mtDNA integrity were determined during and at the end of perfusion, respectively. RESULTS AND

conclusionsMitochondria-targeted OGG1 attenuated indices of lung endothelial dysfunction incurred after a 1h post-mortem period. Oxidative lung tissue mtDNA damage as well as accumulation of proinflammatory mtDNA fragments in lung perfusate, but not nuclear DNA fragments, also were reduced by mitochondria-targeted OGG1. A repair-deficient mt-OGG1 mutant failed to protect lungs from the adverse effects of DCD procurement.

conclusionsThese findings suggest that endothelial barrier dysfunction in lungs procured after DCD is driven by mtDNA damage and point to strategies to enhance mtDNA repair in concert with EVLP as a means of alleviating DCD-related lung IR injury.

Indexed as

AllograftsAnimalsDisease Models, AnimalDNA GlycosylasesDNA, MitochondrialDNA RepairEndothelium, VascularHumansLungLung TransplantationMaleMitochondriaOxidative StressPerfusionRatsRecombinant Fusion ProteinsDNA GlycosylasesDNA, MitochondrialRecombinant Fusion ProteinsLung IR injuryLung transplantmtDNA damagemtDNA DAMPs

Identifiers

PMID31421373
PMCPMC6900440
OpenAlexW2967007707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.